Research Frontiers (REFR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1985 | 12-1984 | |
| Sales | 87 | 35 |
| Gross Profit | 87 | 35 |
| Operating Expenses | 409 | 285 |
| Operating Income | -322 | -250 |
| Interest Expense | 167 | 145 |
| Other Income | 3 | 1 |
| Pre-tax Income | -486 | -395 |
| Net Income Continuous | -486 | -395 |
| Net Income | $-486 | $-395 |
| EPS Basic Total Ops | -0.26 | N/A |
| EPS Basic Continuous Ops | -0.21 | N/A |
| EPS Diluted Total Ops | -0.21 | N/A |
| EPS Diluted Continuous Ops | -0.21 | N/A |
| EBITDA(a) | $-320 | $-250 |